Pages that link to "Q37257460"
Jump to navigation
Jump to search
The following pages link to State of the art: using natriuretic peptide levels in clinical practice (Q37257460):
Displaying 50 items.
- Focus on renal congestion in heart failure (Q26769905) (← links)
- Post-acute care: the role of natriuretic peptides (Q26852607) (← links)
- Cardiac biomarkers: new tools for heart failure management (Q26991726) (← links)
- Early management of patients with acute heart failure: state of the art and future directions. A consensus document from the society for academic emergency medicine/heart failure society of America acute heart failure working group (Q27000455) (← links)
- Morbid obesity: obscuring the diagnosis of aortic stenosis in a patient with cardiogenic wheezing (Q27005608) (← links)
- Heart failure in sub-Saharan Africa: review of the aetiology of heart failure and the role of point-of-care biomarker diagnostics (Q27015261) (← links)
- Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure (Q27027081) (← links)
- Challenges in acute heart failure clinical management: optimizing care despite incomplete evidence and imperfect drugs (Q28085736) (← links)
- Erythrocyte transketolase activity, markers of cardiac dysfunction and the diagnosis of infantile beriberi (Q28477219) (← links)
- Changes of plasma B-type natriuretic peptide levels after high-pressure post-dilation following coronary stent deployment (Q28536414) (← links)
- Acute Heart Failure Registry: Risk Assessment Model in Decompensated Heart Failure (Q30100975) (← links)
- Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease (Q30234679) (← links)
- Pathophysiology of Heart Failure (Q30315815) (← links)
- The Relation Between Global Longitudinal Strain and Serum Natriuretic Peptide Is More Strict Than That Found Between the Latter and Left Ventricular Ejection Fraction: A Retrospective Study in Chronic Heart Failure (Q30398937) (← links)
- Consequences of high-sensitivity troponin T testing applied in a primary care population with chest pain compared with a commercially available point-of-care troponin T analysis: an observational prospective study. (Q30409147) (← links)
- Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trials (Q30413291) (← links)
- Soluble ST2 as a Diagnostic and Prognostic Marker for Acute Heart Failure Syndromes. (Q30458086) (← links)
- Relationship between natriuretic peptides and echocardiography parameters in patients with poorly regulated type 2 diabetes (Q30481117) (← links)
- Effect of pioglitazone versus insulin glargine on cardiac size, function, and measures of fluid retention in patients with type 2 diabetes (Q30490289) (← links)
- Dilated cardiomyopathy (Q33158421) (← links)
- Early postoperative mortality in the elderly: a pilot study (Q33477102) (← links)
- The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial (Q33526184) (← links)
- Effectiveness of a multidisciplinary heart failure disease management programme on 1-year mortality: Prospective cohort study (Q33595106) (← links)
- Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist. (Q33741091) (← links)
- Additive value of blood neutrophil gelatinase-associated lipocalin to clinical judgement in acute kidney injury diagnosis and mortality prediction in patients hospitalized from the emergency department (Q33749925) (← links)
- Usefulness of combining galectin-3 and BIVA assessments in predicting short- and long-term events in patients admitted for acute heart failure (Q33912126) (← links)
- Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery (Q33918932) (← links)
- Systemic sclerosis and the heart: current diagnosis and management (Q34012584) (← links)
- In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study. (Q34027034) (← links)
- B-type natriuretic peptide-guided therapy for perioperative medicine? (Q34304406) (← links)
- The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction (Q34343385) (← links)
- Heart failure and chronic obstructive pulmonary disease: Two for tea or tea for two? (Q34390635) (← links)
- Two Problems With Analyzing Natriuretic Peptide Levels: Obesity and Acute Myocardial Infarction (Q34434678) (← links)
- Prognostic significance of a multimarker strategy of biomarkers in acute heart failure (Q34479808) (← links)
- Utility of biomarkers in the differential diagnosis of heart failure in older people: findings from the heart failure in care homes (HFinCH) diagnostic accuracy study (Q34551529) (← links)
- MR-proANP improves prediction of mortality and cardiovascular events in patients with STEMI. (Q34662255) (← links)
- Early diagnosis of rats with acute myocardial infarction by measurement of brain natriuretic peptide (Q34676067) (← links)
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contrib (Q34677347) (← links)
- Brain natriuretic peptide is not predictive of dilated cardiomyopathy in Becker and Duchenne muscular dystrophy patients and carriers (Q34840485) (← links)
- Improving Prognosis Estimation in Patients with Heart Failure and the Cardiorenal Syndrome (Q35020305) (← links)
- Early management of patients with acute heart failure: state of the art and future directions--a consensus document from the SAEM/HFSA acute heart failure working group (Q35057622) (← links)
- Elevated Levels of N-Terminal Pro-Brain Natriuretic Peptide in Patients with Chronic Dyspnea and Moderate Renal Dysfunction: Decreased Clearance or Increased Cardiac Stress? (Q35123616) (← links)
- Evolution of biomarker guided therapy for heart failure: current concepts and trial evidence. (Q35139977) (← links)
- Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels. (Q35151512) (← links)
- Diagnostic and prognostic utilities of multimarkers approach using procalcitonin, B-type natriuretic peptide, and neutrophil gelatinase-associated lipocalin in critically ill patients with suspected sepsis (Q35156585) (← links)
- Brain natriuretic peptide release in acute myocardial infarction (Q35184348) (← links)
- BNP was associated with ischemic myocardial scintigraphy and death in patients at chest pain unit (Q35292436) (← links)
- Combined biomarker analysis for risk of acute kidney injury in patients with ST-segment elevation myocardial infarction (Q35326877) (← links)
- Biomarkers: hopes and challenges in the path from discovery to clinical practice. (Q35471494) (← links)
- Alterations of serum brain type natriuretic peptide (BNP) in patients with Crimean-Congo hemorrhagic fever (Q35481345) (← links)